The Achilles heel of endothelin receptor therapy for pulmonary arterial hypertension.
作者信息
Corris P A, Langleben D
出版信息
Eur Respir J. 2010 Feb;35(2):460-1; author reply 461. doi: 10.1183/09031936.00160309.
PMID:20123858
Abstract
摘要
相似文献
1
The Achilles heel of endothelin receptor therapy for pulmonary arterial hypertension.
Eur Respir J. 2010 Feb;35(2):460-1; author reply 461. doi: 10.1183/09031936.00160309.
2
[Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension].
Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S177-8. doi: 10.1055/s-0029-1225320. Epub 2009 Aug 28.
3
Liver toxicity of sitaxentan in pulmonary arterial hypertension.
Eur Heart J. 2011 Feb;32(4):386-7.
4
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension.
Eur Respir J. 2009 Sep;34(3):770-1. doi: 10.1183/09031936.00058409.
5
Pulmonary hypertension: basic concepts and practical management.肺动脉高压：基本概念与实际管理
Eur Respir J. 2008 Feb;31(2):236-7. doi: 10.1183/09031936.00134407.
6
Sitaxsentan-induced acute severe hepatitis treated with glucocorticoid therapy.西他沙星致急性重型肝炎应用糖皮质激素治疗
Can Respir J. 2012 Jan-Feb;19(1):e1-2. doi: 10.1155/2012/567024.
7
Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?肝毒性：内皮素受体拮抗剂治疗的致命弱点？
Eur Respir J. 2009 Sep;34(3):529-30. doi: 10.1183/09031936.00094409.
8
Endothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertension.健康与疾病中的内皮素：内皮素受体拮抗剂在肺动脉高压治疗中的应用
J Cardiovasc Pharmacol Ther. 2002 Jan;7(1):9-19. doi: 10.1177/107424840200700i102.
9
Endothelin receptor antagonists in pulmonary arterial hypertension.肺动脉高压中的内皮素受体拮抗剂
Eur Respir J. 2008 Feb;31(2):407-15. doi: 10.1183/09031936.00078207.
10
Sitaxsentan sodium for pulmonary hypertension.用于治疗肺动脉高压的西他生坦钠
Drugs Today (Barc). 2008 Aug;44(8):585-600. doi: 10.1358/dot.2008.44.8.1239808.
Zotero 插件